KVUE Quote, Financials, Valuation and Earnings

Kimberly-Clark Corp. has a net margin of 10.58% compared to Kenvue, Inc.'s net margin of 8.29%. Kenvue, Inc.'s return on equity of 13.85% beat Kimberly-Clark Corp.'s return on equity of 135.54%.

Kenvue, Inc. has a consensus price target of $19.33, signalling upside risk potential of 14.94%. On the other hand Kimberly-Clark Corp. has an analysts' consensus of $127.40 which suggests that it could grow by 29.91%. Given that Kimberly-Clark Corp. has higher upside potential than Kenvue, Inc., analysts believe Kimberly-Clark Corp. is more attractive than Kenvue, Inc..

Kenvue, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Kimberly-Clark Corp. has a beta of 0.264, suggesting its less volatile than the S&P 500 by 73.574%.

Kenvue, Inc. has a quarterly dividend of $0.21 per share corresponding to a yield of 4.91%. Kimberly-Clark Corp. offers a yield of 5.14% to investors and pays a quarterly dividend of $1.26 per share. Kenvue, Inc. pays 150.5% of its earnings as a dividend. Kimberly-Clark Corp. pays out 64.62% of its earnings as a dividend. Kimberly-Clark Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Kenvue, Inc.'s is not.

Kenvue, Inc. quarterly revenues are $3.8B, which are smaller than Kimberly-Clark Corp. quarterly revenues of $4.2B. Kenvue, Inc.'s net income of $398M is higher than Kimberly-Clark Corp.'s net income of $344M. Notably, Kenvue, Inc.'s price-to-earnings ratio is 22.61x while Kimberly-Clark Corp.'s PE ratio is 16.61x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Kenvue, Inc. is 2.16x versus 1.81x for Kimberly-Clark Corp.. Usually stocks with elevated PS ratios are considered overvalued.

The Beauty Health Co. has a net margin of 10.58% compared to Kenvue, Inc.'s net margin of -15.61%. Kenvue, Inc.'s return on equity of 13.85% beat The Beauty Health Co.'s return on equity of -19.76%.

Kenvue, Inc. has a consensus price target of $19.33, signalling upside risk potential of 14.94%. On the other hand The Beauty Health Co. has an analysts' consensus of $1.93 which suggests that it could grow by 37.12%. Given that The Beauty Health Co. has higher upside potential than Kenvue, Inc., analysts believe The Beauty Health Co. is more attractive than Kenvue, Inc..

Kenvue, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison The Beauty Health Co. has a beta of 1.162, suggesting its more volatile than the S&P 500 by 16.231%.

Kenvue, Inc. has a quarterly dividend of $0.21 per share corresponding to a yield of 4.91%. The Beauty Health Co. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Kenvue, Inc. pays 150.5% of its earnings as a dividend. The Beauty Health Co. pays out -- of its earnings as a dividend.

Kenvue, Inc. quarterly revenues are $3.8B, which are larger than The Beauty Health Co. quarterly revenues of $70.7M. Kenvue, Inc.'s net income of $398M is higher than The Beauty Health Co.'s net income of -$11M. Notably, Kenvue, Inc.'s price-to-earnings ratio is 22.61x while The Beauty Health Co.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Kenvue, Inc. is 2.16x versus 0.60x for The Beauty Health Co.. Usually stocks with elevated PS ratios are considered overvalued.

Solesence, Inc. has a net margin of 10.58% compared to Kenvue, Inc.'s net margin of -7.67%. Kenvue, Inc.'s return on equity of 13.85% beat Solesence, Inc.'s return on equity of 6.62%.

Kenvue, Inc. has a consensus price target of $19.33, signalling upside risk potential of 14.94%. On the other hand Solesence, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Kenvue, Inc. has higher upside potential than Solesence, Inc., analysts believe Kenvue, Inc. is more attractive than Solesence, Inc..

Kenvue, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Solesence, Inc. has a beta of 1.083, suggesting its more volatile than the S&P 500 by 8.259%.

Kenvue, Inc. has a quarterly dividend of $0.21 per share corresponding to a yield of 4.91%. Solesence, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Kenvue, Inc. pays 150.5% of its earnings as a dividend. Solesence, Inc. pays out -- of its earnings as a dividend.

Kenvue, Inc. quarterly revenues are $3.8B, which are larger than Solesence, Inc. quarterly revenues of $14.6M. Kenvue, Inc.'s net income of $398M is higher than Solesence, Inc.'s net income of -$1.1M. Notably, Kenvue, Inc.'s price-to-earnings ratio is 22.61x while Solesence, Inc.'s PE ratio is 112.86x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Kenvue, Inc. is 2.16x versus 1.82x for Solesence, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Waldencast Plc has a net margin of 10.58% compared to Kenvue, Inc.'s net margin of --. Kenvue, Inc.'s return on equity of 13.85% beat Waldencast Plc's return on equity of -5.64%.

Kenvue, Inc. has a consensus price target of $19.33, signalling upside risk potential of 14.94%. On the other hand Waldencast Plc has an analysts' consensus of $3.20 which suggests that it could grow by 97.53%. Given that Waldencast Plc has higher upside potential than Kenvue, Inc., analysts believe Waldencast Plc is more attractive than Kenvue, Inc..

Kenvue, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Waldencast Plc has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Kenvue, Inc. has a quarterly dividend of $0.21 per share corresponding to a yield of 4.91%. Waldencast Plc offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Kenvue, Inc. pays 150.5% of its earnings as a dividend. Waldencast Plc pays out -- of its earnings as a dividend.

Kenvue, Inc. quarterly revenues are $3.8B, which are larger than Waldencast Plc quarterly revenues of --. Kenvue, Inc.'s net income of $398M is higher than Waldencast Plc's net income of --. Notably, Kenvue, Inc.'s price-to-earnings ratio is 22.61x while Waldencast Plc's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Kenvue, Inc. is 2.16x versus 0.66x for Waldencast Plc. Usually stocks with elevated PS ratios are considered overvalued.